What have you seen in 2018? A New Drug Update

Activity Details
  • Credit Type: CPE
  • Credit Amount: 1.00
  • Cost: Free
  • Release: Feb 1, 2019
  • Expires: Oct 5, 2021
  • Estimated Time to Complete:
    1 Hour(s)
  • Average User Rating:
    ( Ratings)
Didin't officially launch until November 20, 2019

Faculty

Julie N.  Burris Julie N. Burris, PharmD
Assistant Professor, Clinical & Administrative Sciences
The Center for Health & Wellness (CHW)
Sullivan University College of Pharmacy
Louisville, Kentucky

Needs Statement

Availability of new drugs and biological products leads to new treatment options for patients and advances in health care for the American public. Pharmacist recognition for services will result in a team-based, patient-centered health care system providing improved care and value.

Target Audience

Pharmacists

Objectives

Upon completion of this activity, participants will be able to:
1. Review the mechanism of action and dosing parameters for each new drug
2. Identify key counseling points for patients
3. Summarize each new drug’s place in therapy

Accreditation

CPE
ACPEThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0022-0000-18-174-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Faculty Disclosure

No speakers, planners, or content reviewers have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.